The Interplay of Obesity and Psoriatic Diseases: Inflammatory Pathways, Emerging Treatments, and Interdisciplinary Strategies for Improved Patient Outcomes

Go Back

CME Session Information

Commercial Support:

This CME activity is supported by an educational grant from Eli Lilly and Company.

Learning Objectives:

• Assess the underlying and overlapping inflammatory pathways in obesity and psoriatic diseases (PsD). 
• Recognize the impact of obesity and weight loss on disease-specific and patient-reported outcomes in patients with PsD. 
• Evaluate new and emerging treatment options for obesity based on mechanisms of action, efficacy and safety data, and patient eligibility. 
• Apply current evidence, patient factors, and interdisciplinary strategies to make individualized treatment decisions for patients with obesity and PsD.   

Agenda: 

• Inflammatory Pathways in Obesity and Correlation with Psoriatic Diseases. 
• Impact of Obesity on Psoriatic Diseases, Comorbidities, and Patient Outcomes. 
• New and Emerging Treatment Options for Patients with Obesity and Psoriatic Diseases. 
• Interdisciplinary Strategies for Personalized Obesity Management in Patients with Psoriatic Diseases.

Program Overview

Join us for an insightful webinar exploring the intricate relationship between obesity and psoriatic diseases (PsD), and the groundbreaking potential of GLP-1 receptor agonists (RAs) in transforming care. 

Obesity not only exacerbates the risk and severity of PsD, but also perpetuates a cycle of chronic inflammation and metabolic dysfunction, worsening patient health and outcomes.

While a multidisciplinary approach to obesity management is crucial, new GLP-1 receptor agonists (RAs) have demonstrated benefits not only in weight management but also in reducing inflammation. Given this, several recent and ongoing clinical trials are investigating GLP-1 RAs in the setting of obesity and psoriatic diseases.

In this webinar, leading rheumatology and endocrinology experts will navigate through the impact and overlap of obesity, inflammation, and PsD; key clinical data on GLP-1 RAs; and practical insights on the introduction of these novel therapies into rheumatology care. 

Plus, you can earn 1.5 CME/MOC! Register now for FREE. 

How To Participate 

This is a virtual event, so please register following these 3 easy steps:

1. Go to our registration page and register for the Summit.
2. Save your registration email with your link and login information.
3. Log in to the virtual meeting app during the Summit to participate!

The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!

Please note: you must register and complete the poll/survey questions in the virtual meeting app to claim your free CME credits.

Summit Details

Date: March 22nd, 2025  

Time: 12:00 PM – 15:20 EST

Location: Virtual with Community Watch Parties*

* Join a Local Watch Party to network with your colleagues and enjoy a memorable meal while watching the presentations. Locations will be added over time; you can register now as a virtual attendee and modify your registration to pick a Watch Party later.

Program

12:00-12:10 - Welcome Remarks

Chairs:

• Grace C. Wright, MD, PhD, FACR
  AWIR President and Founder
• Catherine Bakewell, MD, RhMSUS
  AWIR Director, and Local Chapter Leader for Salt Lake City 

12:10-13:40 – Accredited Session (1.5-CME/MOC):
The Interplay of Obesity and Psoriatic Diseases: Inflammatory Pathways, Emerging Treatments, and Interdisciplinary Strategies for Improved Patient Outcomes

Speakers: 

• Alexis R. Ogdie, MD, MSCE

       Deputy Director of the Center for Clinical Epidemiology and Biostatistics

       Perelman School of Medicine, University of Pennsylvania

• Willa Hsueh, MD

       Director, Diabetes and Metabolism Research Center

       Ohio State University, Wexner Medical Center.

This CME activity is supported by an educational grant from Eli Lilly and Company.

13:40-13:55 – Break

13:55-14:10 – Roundtable

14:10-14:40 – Educational Symposium (Not accredited)

 Shifting Scales – The Dual Challenge of Obesity and Psoriatic Arthritis

14:40-14:50 – Closing Remarks

Registration link: Coming Soon

Summit Sponsors: